Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 12:2019:3196723.
doi: 10.1155/2019/3196723. eCollection 2019.

In Vitro Evaluation of the Biological Availability of Hyaluronic Acid Polyethylene Glycols-Cross-Linked Hydrogels to Bovine Testes Hyaluronidase

N Zerbinati  1 , R Mocchi  2 , H Galadari  3 , C Maccario  2 , M Maggi  4 , R Rauso  5 , A Passi  1 , C Esposito  6 , S Sommatis  2
Affiliations

In Vitro Evaluation of the Biological Availability of Hyaluronic Acid Polyethylene Glycols-Cross-Linked Hydrogels to Bovine Testes Hyaluronidase

N Zerbinati et al. Biomed Res Int. .

Abstract

During last years, hyaluronic acid- (HA-) based dermal fillers have grown rapidly and continuously, as reported by the American Society of Aesthetic Plastic Surgery (ASAPS). In fact, HA fillers are considered the gold standard technique for soft tissue augmentation, deep skin hydration, and facial recontouring, playing a key role as an alternative to plastic surgery. HA fillers are less invasive, more biocompatible, and safer and with a more natural and immediate result if compared to plastic surgery. Hence, the safety of HA-based dermal fillers plays a crucial role, mostly in terms of biocompatibility and adjustability in case of unpleasant results and side effects such as, tyndall effect, edema, or granulomas. Hyaluronidase is a naturally occurring enzyme, present in the human body, and can degrade HA fillers avoiding more severe complications. In this article, we analyzed the bioavailability of hyaluronidase degradation of five fillers of Neauvia® hydrogels line (MatexLab SA, Lugano, CH), composed of pure hyaluronic acid and based on PEGDE cross-linking (polyethylene glycol) technology that guarantees a higher biocompatibility and an optimal biointegration and rheological characteristics. The performed in vitro testing is based on the colorimetric determination of the N-acetyl-D-glucosamine (NAG) present in solution after incubation with hyaluronidase, determined at different time points in order to assess the kinetic of each product degradation (1h, 3h, 6h, 24h, 48h, 72h, 120h, and 168h). The aim of this study was to assess, in vitro, how the difference in HA content and PEGDE concentration of the analyzed fillers can influence the product biocompatibility, intended as product enzymatic clearance and duration in time. The results demonstrated that the method was reproducible and easy to perform and that all the analyzed fillers are naturally immediately available for hyaluronidase-mediated degradation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
PEGDE structure and crosslinking with two molecules of hyaluronic acid.
Figure 2
Figure 2
Hydrogels sensitivity to hyaluronidase. Absorbance values obtained after colorimetric NAG assay. Values are normalized for sample content in HA.
Figure 3
Figure 3
Percentage of NAG released after hyaluronidase degradation assay. Data were plotted using the hyperbola equation.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Allemann I. B., Baumann L. Hyaluronic acid gel (Juvederm™) preparations in the treatment of facial wrinkles and folds. Clinical Interventions in Aging. 2008;3(4):629–634. - PMC - PubMed
    1. Beasley K. L., Weiss M. A., Weiss R. A. Hyaluronic acid fillers: a comprehensive review. Facial Plastic Surgery. 2009;25(2):86–94. doi: 10.1055/s-0029-1220647. - DOI - PubMed
    1. Lupo M. P. Hyaluronic acid fillers in facial rejuvenation. Seminars in Cutaneous Medicine and Surgery. 2006;25(3):122–126. doi: 10.1016/j.sder.2006.06.011. - DOI - PubMed
    1. Rivkin A. New fillers under consideration: what is the future of injectable aesthetics? Facial Plastic Surgery. 2009;25(2):120–123. doi: 10.1055/s-0029-1220652. - DOI - PubMed
    1. Funt D., Pavicic T. Dermal fillers in aesthetics: an overview of adverse events and treatment approaches. Clinical, Cosmetic and Investigational Dermatology. 2013;6:295–316. - PMC - PubMed

Publication types

LinkOut - more resources